National Institute for Health Research: Blood Thinners May Improve Survival in 'Moderately Ill' COVID Patients
August 07, 2021
August 07, 2021
LONDON, England, Aug. 7 (TNSJou) -- The National Institute for Health Research issued the following news:
Three international clinical trial platforms, working together to test the effects of anticoagulants (blood thinners) in hospitalised people with COVID-19, have found the treatment improves survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients.
The findings, published in the New England Journal of Medicine th . . .
Three international clinical trial platforms, working together to test the effects of anticoagulants (blood thinners) in hospitalised people with COVID-19, have found the treatment improves survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients.
The findings, published in the New England Journal of Medicine th . . .